MCB: CAR T Cells: Development, Characterization and Applications, Volume 167 in the Methods in Cell Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR T-cell therapy, Determination of the Biodistribution of Chimeric Antigen Receptor-Modified T Cells against CD19 in NSG Mice,� Generation of CAR-T cells using lentiviral vectors, Generation of CAR T-cells using ?-retroviral vector, Flow cytometry detection and quantification of CAR T cells into solid tumors, Evaluation of CAR-T Cell Cytotoxicity: Real-Time Impedance-Based Analysis, and much more.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR T-cell therapy Renpeng Ding, Cheng-Chi Chao and Qianqian Gao 2. Determination of the biodistribution of chimeric antigen receptor-modified T cells against CD19 in NSG mice Hairuo Wen, Ying Huang, Tiantian Hou, Junzhi Wang and Yan Huo 3. Generation of CAR-T cells using lentiviral vectors Mansour Poorebrahim, Isaac Quiros-Fernandez, Elham Fakhr and Angel Cid-Arregui 4. Phenotyping of CAR T cells Sanjay Rathod 5. Evaluation of CAR-T cell cytotoxicity: Real-time impedance-based analysis Amanda N. Lisby, Robert D. Carlson, Trevor R. Baybutt, Megan Weindorfer and Adam E. Snook 6. Flow cytometry detection and quantification of CAR T cells into solid tumors Nicholas J.A. Tokarew, Javier Su?rez Gos?lvez, Alessia Nottebrock, Daria Briukhovestka, Stefan Endres, Bruno L. Cadilha and Sebastian Kobold 7. Generation and functional characterization of CAR exosomes Chuqi Wang, Wenyan Fu, Changhai Lei and Shi Hu 8. Preclinical testing of CAR T cells in zebrafish xenografts Sarah Grissenberger, Benjamin Salzer, Susana Pascoal, Andrea Wenninger-Weinzierl, Manfred Lehner and Martin Distel 9. In vivo experimental mouse model to test CD19 CAR T cells generated with different methods Anne F?ne, Marit Ren?e Myhre, Else Marit Inderberg and S?bastien W?lchli 10. Non-invasive fluorescence imaging for tracking immune cells in preclinical models of immunotherapy Marcelo de Souza Fernandes Pereira, Aarohi Thakkar and Dean Anthony Lee 11. Generation of CAR T-cells using ?-retroviral vector Norihiro Watanabe and Mary Kathryn McKenna 12. Methods to monitor in vivo expansion and efficacy of CAR-T cells in preclinical models Mohammad Alhomoud, Jeremie Martinet, Mayumi Sugita, Alexandra Gomez-Arteaga and Monica L. Guzman 13. Strategies for manufacturing cell therapy products aligned with patient needs Prajna Guha and Steven C. KatzAuthors
Lorenzo Galluzzi Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA. Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome "La Sapienza�. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience. Sheila Spada Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. Sheila Spada is at Weill Cornell Medical College, NY, USA
